Okyo Pharma Ltd. (OKYO)
NASDAQ · Healthcare
Okyo Pharma Ltd. Revenue 2020–2025
Okyo Pharma Ltd. annual/quarterly revenue history and growth rate from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Okyo Pharma Ltd. annual revenue for 2025 was 0.
- Okyo Pharma Ltd. annual revenue for 2024 was 0.
- Okyo Pharma Ltd. annual revenue for 2023 was 0.
- Okyo Pharma Ltd. annual revenue for 2022 was 0.
No data available.
Okyo Pharma Ltd. (OKYO) — Frequently Asked Questions
Okyo Pharma Ltd. (OKYO) is a publicly traded US company. It has a market capitalization of $61M. Explore OKYO's stock price, financial statements, earnings history, margins and key ratios below.
What is Okyo Pharma Ltd.'s market cap?
Okyo Pharma Ltd. (OKYO) has a market capitalization of $61M.
What is the OKYO stock price?
OKYO trades at $1.54 (+3.36% on the day).
Is OKYO profitable?
In fiscal 2025, Okyo Pharma Ltd. reported net income of -$5M.